Estrogen cream after hysterectomy for transgender men
Part of Mental health clinical trials.
This study tests whether using a topical estrogen cream after hysterectomy surgery can help transgender men have a better recovery. Participants will be randomly assigned to use the cream or not, and researchers will follow up by text message.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a transgender man or gender diverse person
- You are 18 years or older
- You have been taking testosterone for at least 6 months and are scheduled for a gender-affirming hysterectomy
- You are willing to use a vaginal estrogen cream after surgery as part of the study
- You have no known allergies to estrogen
- You can read English or Spanish and have a phone that can receive text messages
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a counseling approach to help transmasculine and non-binary people prepare for a hysterectomy (removal of the uterus) as part of gender-affirming care. The goal is to see if this counseling improves knowledge and decision-making.
This study looks at how transgender men and their partners use erectile aids after phalloplasty or metoidioplasty. It hopes to improve sexual health and satisfaction after surgery.
This study tests a special education program for women who have had their uterus removed (hysterectomy). The program is designed to help women feel more confident, improve self-esteem, and enjoy a better quality of life after surgery. It involves online sessions that you can join from home.
This study looks at whether resistance training (like lifting weights) can help transgender women and gender-diverse people assigned male at birth who are starting estrogen and testosterone-blocking medications. It aims to see if exercise improves health and well-being.
This study looks at the tissue from the uterus and cervix of transgender men who are on testosterone therapy and have gender-affirming surgery to remove those organs. The goal is to understand how long-term testosterone affects these tissues.
This study looks at how to best screen for cervical and endometrial (uterine lining) cancer in transgender and gender-diverse people who have had or plan to have a hysterectomy (surgery to remove the uterus and cervix). It aims to make screening more comfortable and effective for this community.
Hear when a new Postoperative Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.